• Info
  • Insider Ownership

Insider Trading & Ownership of Mr. Chirfi Guindo

Location
Cambridge, MA
Summary
The estimated net worth of Mr. Chirfi Guindo is at least $15,712,198 dollars as of 12 Feb 2026. Mr. Chirfi Guindo is the Chief Marketing Officer of Merck & Co., Inc. and owns shares of Merck & Co., Inc. (MRK) stock worth about $10.62M. Mr. Chirfi Guindo is the Head of Glob Prod Strat & Com of BIOGEN INC. and owns shares of BIOGEN INC. (BIIB) stock worth about $4.14M. Mr. Chirfi Guindo is the Director of Beam Therapeutics Inc. and owns shares of Beam Therapeutics Inc. (BEAM) stock worth about $953.7K.
Signature
/s/ Kelly Grez, as attorney-in-fact for Mr. Chirfi Guindo
All Insider Reports
All Insider Reports

Follow Filing Activity

Follow Mr. Chirfi Guindo and return when a new Insider Trading filing appears.

This tracks SEC filing changes for this page using existing product update flows.

Sponsored

Quick Takeaways

  • Mr. Chirfi Guindo has 3 issuer positions tracked on this page.
  • Estimated disclosed ownership value: $15,712,198.
  • Recent insider filing activity is available below.

What Changed

  • Largest disclosed position: Merck & Co., Inc. ($10,618,772).
  • Past-year value change for that position: -$4,836,339.

Why This Matters

  • This page translates Forms 3/4/5 into a quick ownership context before you inspect each transaction row.
  • You can cross-check role, issuer, and filing chronology directly against the SEC source.

Official SEC Source

Filed on Form 4

Insider ownership context is sourced from SEC Forms 3, 4, and 5.

See Original Filing

Ownership of Mr. Chirfi Guindo

Symbol Company Relationship Holdings Value Past Year Net Change Change % Report Period
MRK Merck & Co., Inc. Chief Marketing Officer $10,618,772 -$4,836,339 -31% 12 Feb 2026
BIIB BIOGEN INC. Head of Glob Prod Strat & Com $4,139,728 18 Feb 2022
BEAM Beam Therapeutics Inc. Director $953,698 04 Jun 2025

Insider Transactions Reported by Mr. Chirfi Guindo:

Sym Company Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.